These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12209478)

  • 1. The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors.
    Strand V; Hochberg MC
    Arthritis Rheum; 2002 Aug; 47(4):349-55. PubMed ID: 12209478
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclooxygenase (COX-2) selective inhibitors. Any better than NSAIDs?
    Nguyen A; Chaiton A
    Can Fam Physician; 2001 Jul; 47():1398-400. PubMed ID: 11494927
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 4. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?
    Messerli FH; Sichrovsky T
    Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences between COX-2-specific inhibitors: clinical and economic implications.
    Sonnenblick EH
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
    Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A
    J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.
    Spalding WM; Reeves MJ; Whelton A
    Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall].
    Meyer CH
    Klin Monbl Augenheilkd; 2005 Jan; 222(1):62-3. PubMed ID: 15678404
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of selective cyclooxygenase-2 inhibitors.
    Krum H; Liew D; Aw J; Haas S
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):265-70. PubMed ID: 15151474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is concern about cardiovascular events with the new coxib class of drugs justified?
    Schnitzer TJ
    Medscape Womens Health; 2001 Oct; 6(5):8. PubMed ID: 11698930
    [No Abstract]   [Full Text] [Related]  

  • 11. Why don't we initiate more large simple randomized controlled trials?
    Wright JM
    CMAJ; 2003 Nov; 169(11):1170-1. PubMed ID: 14638653
    [No Abstract]   [Full Text] [Related]  

  • 12. GI events leading to death in association with celecoxib and rofecoxib.
    Weaver J; Bonnel RA; Karwoski CB; Brinker AD; Beitz J
    Am J Gastroenterol; 2001 Dec; 96(12):3449-50. PubMed ID: 11774975
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular safety of COX-2 inhibitors.
    Med Lett Drugs Ther; 2001 Nov; 43(1118):99-100. PubMed ID: 11707751
    [No Abstract]   [Full Text] [Related]  

  • 14. Does the dose make the poison?
    Harris RE
    Science; 2005 Apr; 308(5719):203. PubMed ID: 15821073
    [No Abstract]   [Full Text] [Related]  

  • 15. Pain relief at a price. A blow to the heart?
    Comarow A
    US News World Rep; 2001 Sep; 131(8):45. PubMed ID: 11550395
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Smith ER
    Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
    Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risk associated with celecoxib.
    Brophy JM
    N Engl J Med; 2005 Jun; 352(25):2648-50; author reply 2648-50. PubMed ID: 15972876
    [No Abstract]   [Full Text] [Related]  

  • 19. COX-2 selective inhibitors and heart health.
    Simon LS; White WB
    Postgrad Med; 2005 Jan; 117(1 Suppl):7-20. PubMed ID: 19667717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The CLASS study and its scientific statement. Ethical publishing rules neglected].
    Wollheim FA
    Lakartidningen; 2002 Oct; 99(40):3934-5. PubMed ID: 12422748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.